Marcella Serasin

Bilingual solution-oriented leader with 15+ years of expertise at global biotechnology and healthcare institutions, including managing clinical trials based on deep understanding of pharmaceuticals and products across therapy areas. Demonstrated success developing clinical trial protocols in collaboration with medical professionals, building in flexibility to manage issues and emergencies while ensuring regulatory compliance. Adept at engaging key opinion leaders (KOLs) and other healthcare industry stakeholders leveraging strong problem-solving and interpersonal communication skills. 

A true team player and a fast learner with an agile mindset and focus on curiosity and integrity.

FAMILY TRANSITION TO SWITZERLAND 12/2021 – Present

JOHNSON & JOHNSON MEDICAL S.P.A. (ETHICON DIVISION), Northeastern Region, Italy 07/2010 – 06/2021

Key Account Manager (01/2021 – 06/2021)

Procedural Specialist & Pharma Sales Representative, Cardiovascular Surgery (12/2019 – 01/2021)

Procedural Specialist & Pharma Sales Representative, Ortho-Neuro-Trauma Surgery (04/2013 – 12/2019)

Product Specialist, Biosurgery & Pharma Sales Representative (07/2010 – 04/2013)

Managed portfolio of drugs (haemostatics and blood derivatives) and medical devices (haemostatics, sutures, mechanical instruments, energy instruments) for surgical specialities, including general surgery, neurosurgery, cardiovascular surgery, oncologic surgery, plastic surgery, orthopaedics, gynaecology, urology, and ENT. Drove market share increases through business planning, territory routing, and area budget management.

• Headed clinical studies, protocol development and data collection post-sales, collaborating with pharmacists and doctors to evaluate efficacy and conduct health technology assessments to understand clinical/economic benefits.
• Built trusted relationships with KOLs, physicians, surgeons, nurses, and hospital pharmacists, leading regular training on technical/scientific knowledge, consistently achieving or exceeding sales growth targets, including earning 7% growth in 2019.
• Led new product launches, including fibrin glues, antibacterial and barbed sutures, and haemostatic products, encompassing new-to-market and upgrades. Managed local/regional therapeutic guidelines and public tenders leveraging clinical studies, scientific/technical training, business activities (elaborating strategies, action plains, marketing projects) and winning semestral contest in 2012.
• Managed crisis activity and urgent customer support, including unforeseen backorders and mid-surgery technical-scientific issues.
• Oversaw high-profile marketing projects, such as hospital meetings, courses, conferences, and local/national events.
• Directed business development activities, elaborating strategies and action plans, promoting drugs and medical devices, including launch of new fibrin glue and selection of key opinion leaders evaluating drug efficiency. Supporting market share gain and successful local and regional public tender.
• Ensured compliance with country legislation, industry regulation, and internal policies/practices, including managing reporting.

EYELAB S.P.A (SIFI GROUP), Northeastern Region, Italy  05/2008 – 06/2010

Pharmaceutical Sales Representative

Launched new products for the ophthalmic market after being recruited in the company's startup phase.

• Ranked #2 nationally as Best Performing Sales Rep for pharmaceutical portfolio (2009); led promotion of drugs, medical devices, and supplements and facilitated hospital meetings, courses, conferences, and events.

ALFA INTES-INDUSTRIA TERAPEUTICA SPLENDORE, Northeastern Region, Italy 01/2007 – 04/2008

Pharmaceutical Sales Representative 

Headed promotion, sale, and management of ophthalmology drugs, medical devices, and supplements.

MAZZINI PHARMACY, Venice, Italy | AI COLLI PHARMACY, Padua, Italy 04/2006 – 12/2006

Pharmacist

Dispensed medications according to prescriptions, prepared galenic products, and recommended over-the-counter products. Oversaw warehouse management.

PADUA HOSPITAL (UO NEPHROLOGY & DIALYSIS), Padua, Italy 01/2003 – 01/2004

Pharmacist Intern

Managed co-investigator activity of Amgen multicentric clinical trial for Cinacalcet, a new drug used for treatment of secondary hyperparathyroidism of uremic patients in haemodialysis.

CENTRO IOV – OSPEDALE BUSONERA (ANTIBLASTIC DEPT PHARMACY), Padua, Italy 01/2004 – 06/2004

Pharmacist Intern

Supported management and control of therapeutic protocols for oncology drugs. Managed direct distribution of medicines and galenic preparation of oncological therapies.

LUISS BUSINESS SCHOOL, Rome, Italy 01/2012

Second Level Master, Management of Biomedical Products (Probiomed)

Experimental thesis: Follow up Tabotamp SNoW launch

UNIVERSITÀ DEGLI STUDI DI PADOVA, Padua, Italy 10/2005

Master’s Degree, Pharmacy (Grade 105/110)

Experimental thesis: Multicentre study on the efficacy of a new calcimimetic drug in the treatment of secondary hyperparathyroidism of uremic patients in haemodialysis 

UNIVERSITÀ DEGLI STUDI DI PADOVA, Padua Italy  12/2005

Pharmacist (Professional qualification in Italy)

Canton of Geneva Degree equivalence, Geneva  02/2017

Federal Degree Equivalence, Berne  04/2015